Rondrique, Zhayesha S.
HRN: 21-47-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/14/2023
11/20/2023
IV
250mg
Q8h
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes